SETD7 and neoplasm: Growing evidences obtained on in vitro analyses of SET7/9 functions for methylation of non-histone proteins provide the possibility that SET7/9 exerts tumor suppressor activities through p53 stabilization, pRB activation and DNMT1 degradation [8–11].